ArticleFrontiers in immunology2021

Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.

Murad Abusukhun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.